Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rudwaleit

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Arthritis Research & Therapy|June 18, 2010
Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapyMartin Rudwaleit, Filip Van den Bosch, Martina Kron, et al.
Rheumatology (Oxford, England)|December 14, 2011
Evaluation of the spinal pain score in AS--a psychometric analysisIn-Ho Song, Hildrun Haibel, Elke S Stelling, et al.
Arthritis and Rheumatism|March 13, 2003
Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximabJianxiang Zou, Martin Rudwaleit, Jan Brandt, et al.
Nature Reviews. Rheumatology|October 7, 2010
Justification for including MRI as a tool in the diagnosis of axial SpADésirée van der Heijde, Martin Rudwaleit, Robert B M Landewé, et al.
Annals of the Rheumatic Diseases|April 30, 2016
High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception CohortDenis Poddubnyy, Mikhail Protopopov, Hildrun Haibel, et al.
Arthritis Research & Therapy|October 26, 2017
Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception CohortMikhail Protopopov, Joachim Sieper, Hildrun Haibel, et al.
Clinical Rheumatology|October 2, 2004
An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritisHeiner Appel, Lucia Neure, Maren Kuhne, et al.
Arthritis Research & Therapy|October 24, 2008
Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatmentHeiner Appel, Louise Janssen, Joachim Listing, et al.
Rheumatology (Oxford, England)|May 8, 2010
Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasisJürgen Braun, Martin Rudwaleit, Sonja Kary, et al.
RMD Open|April 20, 2018
Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III studyDésirée van der Heijde, Jürgen Braun, Martin Rudwaleit, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Arthritis Research & Therapy|June 18, 2010
Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapyMartin Rudwaleit, Filip Van den Bosch, Martina Kron, et al.
Rheumatology (Oxford, England)|December 14, 2011
Evaluation of the spinal pain score in AS--a psychometric analysisIn-Ho Song, Hildrun Haibel, Elke S Stelling, et al.
Arthritis and Rheumatism|March 13, 2003
Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximabJianxiang Zou, Martin Rudwaleit, Jan Brandt, et al.
Nature Reviews. Rheumatology|October 7, 2010
Justification for including MRI as a tool in the diagnosis of axial SpADésirée van der Heijde, Martin Rudwaleit, Robert B M Landewé, et al.
Annals of the Rheumatic Diseases|April 30, 2016
High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception CohortDenis Poddubnyy, Mikhail Protopopov, Hildrun Haibel, et al.
Arthritis Research & Therapy|October 26, 2017
Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception CohortMikhail Protopopov, Joachim Sieper, Hildrun Haibel, et al.
Clinical Rheumatology|October 2, 2004
An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritisHeiner Appel, Lucia Neure, Maren Kuhne, et al.
Arthritis Research & Therapy|October 24, 2008
Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatmentHeiner Appel, Louise Janssen, Joachim Listing, et al.
Rheumatology (Oxford, England)|May 8, 2010
Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasisJürgen Braun, Martin Rudwaleit, Sonja Kary, et al.
RMD Open|April 20, 2018
Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III studyDésirée van der Heijde, Jürgen Braun, Martin Rudwaleit, et al.
Pageof 15